Genomics Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Genomics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Genomics Market

5.1. Covid-19: Genomics Industry Impact
5.2. Genomics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Genomics Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Genomics Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Genomics Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Genomics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Genomics Market Revenue by Market Players
7.1.1.2. Genomics Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Genomics Market, By Product Type

8.1. Genomics Market, by Component, 2023-2032
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Systems and software
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Services Equipment
8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Genomics Market, By Application

9.1. Genomics Market, by Application, 2023-2032
9.1.1. Sequencing
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Microarray
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. PCR (polymerase chain reaction)
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Nucleic acid extraction and purification
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Genomics Market, By End-user

10.1. Genomics Market, by End-user, 2023-2032
10.1.1. Diagnostics
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Drug discovery and development
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Precision medicine
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Agriculture and animal research
10.1.5. Other applications

Chapter 11. Global GenomicsMarket, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2021-2032)
11.1.2. Market Revenue Forecast by Application (2021-2032)
11.1.3. Market Revenue Forecast by End-user (2021-2032)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2021-2032)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2021-2032)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2021-2032)
11.2.2. Market Revenue Forecast by Application (2021-2032)
11.2.3. Market Revenue Forecast by End-user (2021-2032)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2021-2032)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2021-2032)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2021-2032)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2021-2032)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2021-2032)
11.3.2. Market Revenue Forecast by Application (2021-2032)
11.3.3. Market Revenue Forecast by End-user (2021-2032)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2021-2032)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2021-2032)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2021-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2021-2032)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2021-2032)
11.4.2. Market Revenue Forecast by Application (2021-2032)
11.4.3. Market Revenue Forecast by End-user (2021-2032)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2021-2032)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2021-2032)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2021-2032)
11.5.2. Market Revenue Forecast by Application (2021-2032)
11.5.3. Market Revenue Forecast by End-user (2021-2032)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2021-2032)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2021-2032)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2021-2032)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2021-2032)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. Illumina, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. Oxford Nanopore Technologies
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. QIAGEN N.V.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. BGI
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. Eurofins Scientific
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. GE Healthcare
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. F. Hoffmann-La Roche Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms